ブックタイトルカテーテル関連尿路感染の予防のためのCDCガイドライン 2009|株式会社メディコン

ページ
76/120

このページは カテーテル関連尿路感染の予防のためのCDCガイドライン 2009|株式会社メディコン の電子ブックに掲載されている76ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「ブックを開く」ボタンをクリックすると今すぐブックを開きます。

概要

カテーテル関連尿路感染の予防のためのCDCガイドライン 2009|株式会社メディコン

bacteriuria inevitably occurs over time either via breaks in the sterile system or via theextraluminal route. 24 The daily risk of bacteriuria with catheterization is 3% to 10%, 25,26approaching 100% after 30 days, which is considered the delineation between short and longtermcatheterization. 27Formation of biofilms by urinary pathogens on the surface of the catheter and drainage systemoccurs universally with prolonged duration of catheterization. 28 Over time, the urinary catheterbecomes colonized with microorganisms living in a sessile state within the biofilm, rendering themresistant to antimicrobials and host defenses and virtually impossible to eradicate withoutremoving the catheter. The role of bacteria within biofilms in the pathogenesis of CAUTI isunknown and is an area requiring further research.The most frequent pathogens associated with CAUTI (combining both ASB and SUTI) in hospitalsreporting to NHSN between 2006-2007 were Escherichia coli (21.4%) and Candida spp (21.0%),followed by Enterococcus spp (14.9%), Pseudomonas aeruginosa (10.0%), Klebsiellapneumoniae (7.7%), and Enterobacter spp (4.1%). A smaller proportion was caused by othergram-negative bacteria and Staphylococcus spp 5 .Antimicrobial resistance among urinary pathogens is an ever increasing problem. About a quarterof E. coli isolates and one third of P. aeruginosa isolates from CAUTI cases were fluoroquinoloneresistant.Resistance of gram-negative pathogens to other agents, including third-generationcephalosporins and carbapenems, was also substantial 5 . The proportion of organisms that weremultidrug-resistant, defined by non-susceptibility to all agents in 4 classes, was 4% of P.aeruginosa, 9% of K. pneumoniae, and 21% of Acinetobacter baumannii. 29< 原文 > V. Background73